BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6326234)

  • 21. The biochemistry and functional morphology of the Entamoeba.
    McLaughlin J; Aley S
    J Protozool; 1985 May; 32(2):221-40. PubMed ID: 2409275
    [No Abstract]   [Full Text] [Related]  

  • 22. Activation of lymphocytes from healthy donors and patients with amebiasis by extracts of Entamoeba histolytica.
    Kettis AA; Sundqvist KG
    Arch Invest Med (Mex); 1982; 13 Suppl 3():245-8. PubMed ID: 6295315
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cellular interactions with E. histolytica trophozoites in experimental amebic infections].
    Villegas-González J; Fastag de Shor A; de la Hoz R; de la Torre M
    Arch Invest Med (Mex); 1974; 5 SUPPL 2():433-40. PubMed ID: 4376928
    [No Abstract]   [Full Text] [Related]  

  • 24. A radioimmunoprecipitation polyethylene glycol assay for circulating Entamoeba histolytica antigens.
    Pillai S; Mohimen A; Mehra S
    J Immunol Methods; 1982 Dec; 55(2):273-6. PubMed ID: 6298310
    [No Abstract]   [Full Text] [Related]  

  • 25. Host-pathogen interaction in amebiasis and progress in vaccine development.
    Huston CD; Petri WA
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):601-14. PubMed ID: 9832261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amebiasis now.
    Ravdin JI
    Am J Trop Med Hyg; 1989 Sep; 41(3 Suppl):40-8. PubMed ID: 2552852
    [No Abstract]   [Full Text] [Related]  

  • 27. Macrophage spreading inhibition test as an alternate method for in vitro assessment of cell-mediated immunity against Entamoeba histolytica.
    Haq A; Sharma A; Ahmad S; Khan N
    Trop Med Parasitol; 1986 Sep; 37(3):248-50. PubMed ID: 2878487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of thin layer immunoassay (TIA) for demonstration of antibodies against Entamoeba histolytica.
    Nilsson LA; Petchclai B; Elwing H
    Am J Trop Med Hyg; 1980 Jul; 29(4):524-9. PubMed ID: 6250415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entamoeba histolytica: pathogenic mechanisms, human immune response, and vaccine development.
    Ravdin JI
    Clin Res; 1990 Apr; 38(2):215-25. PubMed ID: 2186887
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody-dependent lymphocyte mediated cytotoxicity in amoebiasis.
    Vinayak VK; Chugh S; Saxena A; Sharma SP
    Indian J Med Res; 1984 Oct; 80():421-7. PubMed ID: 6099823
    [No Abstract]   [Full Text] [Related]  

  • 31. Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica.
    Salata RA; Martinez-Palomo A; Murray HW; Conales L; Trevino N; Segovia E; Murphy CF; Ravdin JI
    J Immunol; 1986 Apr; 136(7):2633-9. PubMed ID: 2869086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica.
    Ravdin JI; Jackson TF; Petri WA; Murphy CF; Ungar BL; Gathiram V; Skilogiannis J; Simjee AE
    J Infect Dis; 1990 Sep; 162(3):768-72. PubMed ID: 2388003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence of Entamoeba histolytica in rat and its comparison with the serological responses of the amoebic patients.
    Vinayak VK; Sawhney S; Jain P; Chugh S; Naik SR; Chakravarti RN
    Trans R Soc Trop Med Hyg; 1981; 75(1):32-7. PubMed ID: 6267744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed-type hypersensitivity to Entamoeba histolytica in mice and hamsters: a comparison.
    Gold D
    Parasitol Res; 1989; 75(5):335-42. PubMed ID: 2542927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definition of the antigenic pattern of Entamoeba histolytica, and immunoelectrophoretic analysis of the variation of patient response to amebic disease.
    Krupp IM
    Am J Trop Med Hyg; 1977 May; 26(3):387-92. PubMed ID: 194490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [National serologic survey. I. Study of antibodies against E. histolytica in a semirural locality on the Gulf of Mexico Coast].
    Gutiérrez G; Margáin JC; Castañeda R; Enríquez O; Aubanel M; Sepúlveda B
    Arch Invest Med (Mex); 1974; 5 SUPPL 2():475-80. PubMed ID: 4376934
    [No Abstract]   [Full Text] [Related]  

  • 37. The immunopathogenesis of Entamoeba histolytica.
    Mortimer L; Chadee K
    Exp Parasitol; 2010 Nov; 126(3):366-80. PubMed ID: 20303955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the parasite cellular mechanisms involved in the pathogenesis of amebiasis.
    Ravdin JI; Guerrant RL
    Rev Infect Dis; 1982; 4(6):1185-207. PubMed ID: 6296963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Entamoeba histolytica: from adherence to enteropathy.
    Ravdin JI
    J Infect Dis; 1989 Mar; 159(3):420-9. PubMed ID: 2536786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity to amebiasis: new insights and new challenges.
    Stanley SL
    J Infect Dis; 2001 Aug; 184(4):504-6. PubMed ID: 11471109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.